Hurley Capital
ROIV icon

Hurley Capital’s Roivant Sciences ROIV Stock Holding History

Hurley Capital’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.77K Sell
103
-103
-50% -$3.74K ﹤0.01% 490
2026
Q2 		$7.29K Hold
206
– – ﹤0.01% 359
2026
Q1 		$5.71K Buy
+206
New +$5.29K ﹤0.01% 405
2025
Q4 		– Sell
-413
Closed -$6.25K – 728
2025
Q3 		$6.25K Buy
+413
New +$5.11K ﹤0.01% 412

Other funds holding ROIV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $53.6B AUM 32.29% 1-Year Est. Return
Penn Davis McFarland
Penn Davis McFarland Dallas, Texas $1.17B AUM 26.22% 1-Year Est. Return

Hurley Capital's ROIV Position: Q3 2026 in Review

Hurley Capital reduced its Roivant Sciences (ROIV) stake by 50% in Q3 2026, selling an estimated $3.74K and leaving 103 shares worth $3.77K. The position accounts for ﹤0.01% of the portfolio, ranked #490.

Hurley Capital first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. The position peaked at $7.29K in Q2 2026. 215 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Hurley Capital held 103 shares of Roivant Sciences worth $3.77K as of Q3 2026.
  • Hurley Capital sold 103 Roivant Sciences shares in Q3 2026, an estimated $3.74K.
  • Roivant Sciences made up ﹤0.01% of Hurley Capital's portfolio in Q3 2026, its #490 holding.
  • Hurley Capital first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • Hurley Capital's Roivant Sciences position peaked at $7.29K in Q2 2026.
  • 215 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Hurley Capital's 13F filing for Q3 2026, filed 5 Nov 2026.